Novo Nordisk Unveils Wegovy® HD with Unprecedented Weight Loss Results Novo Nordisk receives FDA approval for Wegovy® HD, showcasing significant advancements in weight loss management for obese adults, showing a potential average loss of 21%.

Novo Nordisk Unveils Wegovy® HD with Unprecedented Weight Loss Results #United_States #Novo_Nordisk #Plainsboro #Obesity_Treatment #Wegovy_HD